Avantor Operating Income Over Time
| AVTR Stock | USD 9.03 0.18 1.95% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Avantor Performance and Avantor Correlation. Can Life Sciences Tools & Services industry sustain growth momentum? Does Avantor have expansion opportunities? Factors like these will boost the valuation of Avantor. If investors know Avantor will grow in the future, the company's valuation will be higher. Determining accurate worth demands scrutiny of both present operating results and projected expansion capacity. Evaluating Avantor demands reviewing these metrics collectively while recognizing certain factors exert disproportionate influence.
Quarterly Earnings Growth (0.89) | Earnings Share (0.78) | Revenue Per Share | Quarterly Revenue Growth (0.01) | Return On Assets |
The market value of Avantor is measured differently than its book value, which is the value of Avantor that is recorded on the company's balance sheet. Investors also form their own opinion of Avantor's value that differs from its market value or its book value, called intrinsic value, which is Avantor's true underlying value. Market participants employ diverse analytical approaches to determine fair value and identify buying opportunities when prices dip below calculated worth. Because Avantor's market value can be influenced by many factors that don't directly affect Avantor's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Understanding that Avantor's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Avantor represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Meanwhile, Avantor's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Cross Equities Operating Income Analysis
Compare Avantor and related stocks such as Masimo, AptarGroup, and Repligen Operating Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MASI | (6.9 M) | 86.5 M | 85.2 M | 79.7 M | 103.5 M | 120.2 M | 435.9 M | 183.8 M | 208 M | 221.2 M | 255.8 M | 275.8 M | 210 M | 136.5 M | (266.7 M) | (306.7 M) | (291.4 M) |
| ATR | 35.9 M | 287 M | 258.9 M | 284.6 M | 306.4 M | 324.1 M | 310.5 M | 321.5 M | 286.3 M | 371.7 M | 339.5 M | 347.3 M | 379.3 M | 404 M | 496.5 M | 510.9 M | 536.4 M |
| RGEN | (2.5 M) | (1.1 B) | 11.1 M | 22.9 M | 10.7 M | 13.8 M | 16 M | 14 M | 26 M | 40.1 M | 81.3 M | 167.2 M | 224.7 M | 54.6 M | (35.1 M) | (40.4 M) | (38.4 M) |
| BAX | 265 M | 2.9 B | 3 B | 3 B | 827 M | 613 M | 1.1 B | 1.6 B | 1.8 B | 1.9 B | 1.8 B | 2.1 B | 1.6 B | 903 M | 687 M | 693 M | 658.4 M |
| BIO | 8.7 M | 295.2 M | 264.1 M | 169.5 M | 150 M | 166.7 M | 53.2 M | 116.7 M | (108.6 M) | 229.7 M | 421.3 M | 500.3 M | 482.6 M | 337.8 M | 269 M | 270.5 M | 151.8 M |
| HSIC | (9.5 M) | 582.1 M | 634.2 M | 677.1 M | 715.1 M | 768.9 M | 817.5 M | 864.7 M | 693.5 M | 733 M | 567.4 M | 854.8 M | 938 M | 714 M | 729 M | 838.4 M | 493.6 M |
| STVN | 62.2 M | 62.2 M | 62.2 M | 62.2 M | 62.2 M | 62.2 M | 62.2 M | 62.2 M | 62.2 M | 62.2 M | 103.1 M | 162.2 M | 192.4 M | 200.7 M | 161.1 M | 185.3 M | 161.7 M |
| MOH | 17.5 M | 80.2 M | 41.1 M | 136.6 M | 192.9 M | 387 M | 306 M | (555 M) | 1.1 B | 1 B | 1.1 B | 1 B | 1.2 B | 1.6 B | 1.7 B | 783 M | 443.6 M |
| GRFS | 73.6 M | 278.9 M | 660.1 M | 736.1 M | 857.7 M | 970.4 M | 939.4 M | 1 B | 994.1 M | 1.1 B | 996.1 M | 595.1 M | 782.4 M | 782.3 M | 1.2 B | 1.4 B | 708.3 M |
Avantor and related stocks such as Masimo, AptarGroup, and Repligen Operating Income description
Operating Income is the amount of profit realized from Avantor operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Avantor is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.My Equities
My Current Equities and Potential Positions
| Avantor | AVTR |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Business Address | Radnor Corporate Center, |
| Exchange | New York Stock Exchange |
USD 9.03
Additional Tools for Avantor Stock Analysis
When running Avantor's price analysis, check to measure Avantor's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Avantor is operating at the current time. Most of Avantor's value examination focuses on studying past and present price action to predict the probability of Avantor's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Avantor's price. Additionally, you may evaluate how the addition of Avantor to your portfolios can decrease your overall portfolio volatility.